Patent classifications
C07D319/08
METHOD FOR PREPARING 3-SUBSTITUTED 2-VINYLPHENYL SULFONATES
The present invention relates to a method for preparing 3-substituted 2-vinylphenyl sulfonates.
METHOD FOR PREPARING 3-SUBSTITUTED 2-VINYLPHENYL SULFONATES
The present invention relates to a method for preparing 3-substituted 2-vinylphenyl sulfonates.
Bis-Cyclic Carbonate Molecule with Bis(1,3)-Dioxin-Dione Structure
Bis-cyclic carbonate molecule consisting of at least two (1,3)-dioxine-2-one structures directly linked to each other or indirectly linked via other cycles.
Photolabile acetal and ketal compounds for the controlled release of active volatile carbonyl compounds
A method for releasing one or more active volatile aldehydes or ketones from a delivery system based on photosensitive acetal or ketal compounds capable of liberating upon exposure to light an active volatile carbonyl compound in a controlled manner from a surface into the surrounding environment. The delivery system can be used to release active substances such as flavors, fragrances, malodor counteractants, insect attractants or insect repellents. The invention also relates to the use of such acetal or ketal compounds in perfumery, as well as in perfuming compositions or perfumed consumer articles.
Photolabile acetal and ketal compounds for the controlled release of active volatile carbonyl compounds
A method for releasing one or more active volatile aldehydes or ketones from a delivery system based on photosensitive acetal or ketal compounds capable of liberating upon exposure to light an active volatile carbonyl compound in a controlled manner from a surface into the surrounding environment. The delivery system can be used to release active substances such as flavors, fragrances, malodor counteractants, insect attractants or insect repellents. The invention also relates to the use of such acetal or ketal compounds in perfumery, as well as in perfuming compositions or perfumed consumer articles.
Process for the Production of Cannabinoids and Cannabinoid Acids
The present invention relates to a process for the preparation of diverse known and novel cannabinoids 5, which include cannabigerol (CBG, 1), cannabigerolic acid (CBGA, 2), cannabigerovarin (CBGV, 3), cannabigerovarinic acid (CBGVA, 4) and other naturally occurring monocyclic cannabinoids and other analogues from simple inexpensive starting materials using a cascade sequence of allylic rearrangement and aromatization. Novel cannabinoids of series 5 are also claimed as part of the invention. These synthesized cannabinoids, unlike the minor cannabinoids isolated from Cannabis saliva or synthesized from the condensation reactions such as the reactions of substituted resorcinols with monoterpenes, are much easier to obtain at high purity levels. In particular, these cannabinoids, including but not limited to cannabigerol (CBG, 1), cannabigerolic acid (CBGA, 2), cannabigerovarin (CBGV, 3) and cannabigerovarinic acid (CBGVA, 4) are obtained without contamination with impurities with variation in RA and RB (e.g. contamination of CBG with CBGV).
##STR00001##
Process for the Production of Cannabinoids and Cannabinoid Acids
The present invention relates to a process for the preparation of diverse known and novel cannabinoids 5, which include cannabigerol (CBG, 1), cannabigerolic acid (CBGA, 2), cannabigerovarin (CBGV, 3), cannabigerovarinic acid (CBGVA, 4) and other naturally occurring monocyclic cannabinoids and other analogues from simple inexpensive starting materials using a cascade sequence of allylic rearrangement and aromatization. Novel cannabinoids of series 5 are also claimed as part of the invention. These synthesized cannabinoids, unlike the minor cannabinoids isolated from Cannabis saliva or synthesized from the condensation reactions such as the reactions of substituted resorcinols with monoterpenes, are much easier to obtain at high purity levels. In particular, these cannabinoids, including but not limited to cannabigerol (CBG, 1), cannabigerolic acid (CBGA, 2), cannabigerovarin (CBGV, 3) and cannabigerovarinic acid (CBGVA, 4) are obtained without contamination with impurities with variation in RA and RB (e.g. contamination of CBG with CBGV).
##STR00001##
Salt, acid generator, resist composition and method for producing resist pattern
A salt represented by formula (I), an acid generator and a resist composition: ##STR00001##
wherein R.sup.1, R.sup.2 and R.sup.3 each represent a hydroxy group, OR.sup.10, OCOOR.sup.10, O-L.sup.1-COOR.sup.10; R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 each represent a halogen atom, a hydroxy group, etc.; L.sup.1 represents an alkanediyl group; R.sup.10 represents an acid-labile group; X.sup.1, X.sup.2 and X.sup.3 each represent an oxygen atom or a sulfur atom; m1 and m7 represent an integer of 0 to 5, m2 to m6 and m8, m9 represent an integer of 0 to 4, in which 0m1+m75, 0m2+m84, 0m3+m94, and at least one of m1, m2 and m3 represents an integer of 1 or more; X.sup.4 represents a single bond, CH.sub.2, O, S, etc.; and AI.sup. represents an organic anion.
Salt, acid generator, resist composition and method for producing resist pattern
A salt represented by formula (I), an acid generator and a resist composition: ##STR00001##
wherein R.sup.1, R.sup.2 and R.sup.3 each represent a hydroxy group, OR.sup.10, OCOOR.sup.10, O-L.sup.1-COOR.sup.10; R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 each represent a halogen atom, a hydroxy group, etc.; L.sup.1 represents an alkanediyl group; R.sup.10 represents an acid-labile group; X.sup.1, X.sup.2 and X.sup.3 each represent an oxygen atom or a sulfur atom; m1 and m7 represent an integer of 0 to 5, m2 to m6 and m8, m9 represent an integer of 0 to 4, in which 0m1+m75, 0m2+m84, 0m3+m94, and at least one of m1, m2 and m3 represents an integer of 1 or more; X.sup.4 represents a single bond, CH.sub.2, O, S, etc.; and AI.sup. represents an organic anion.
Compounds and methods for inducing chondrogenesis
Described herein are compounds and compositions for the amelioration of arthritis or joint injuries by inducing mesenchymal stem cells into chondrocytes.